logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203/PPP1R3C/mTOR/Myc axis by Yulai Zhou & Yan Gao & Yinghui Peng & Changjing Cai & Ying Han & Yihong Chen & Gongping Deng & Yanhong Ouyang & Hong Shen & Shan Zeng & Yangfeng Du & Zemin Xiao instant download

  • SKU: EBN-235862486
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.7

11 reviews
Instant download (eBook) QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203/PPP1R3C/mTOR/Myc axis after payment.
Authors:Yulai Zhou & Yan Gao & Yinghui Peng & Changjing Cai & Ying Han & Yihong Chen & Gongping Deng & Yanhong Ouyang & Hong Shen & Shan Zeng & Yangfeng Du & Zemin Xiao
Pages:updating ...
Year:2025
Publisher:x
Language:english
File Size:4.9 MB
Format:pdf
Categories: Ebooks

Product desciption

QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203/PPP1R3C/mTOR/Myc axis by Yulai Zhou & Yan Gao & Yinghui Peng & Changjing Cai & Ying Han & Yihong Chen & Gongping Deng & Yanhong Ouyang & Hong Shen & Shan Zeng & Yangfeng Du & Zemin Xiao instant download

Cell Death Discovery, doi:10.1038/s41420-025-02478-w

Colorectal cancer (CRC) is the third most common cancer and remains a significant challenge due to high rates of drug resistanceand limited therapeutic options. Circular RNAs (circRNAs) are increasingly recognized for their roles in CRC initiation, progression,and drug resistance. However, no circRNA-based therapies have yet entered clinical development, underscoring the need forcomprehensive detection and mechanistic studies of circRNAs in CRC. Here, we identified and characterized a circular RNA,circ_0001766 (hsa_circ_0001766), through microarray analysis of CRC tissues. Our results showed that circ_0001766 is1234567890();,:downregulated in CRC tissues and closely associated with patient survival and metastasis. Functional experiments demonstratedthat circ_0001766 inhibits CRC cell proliferation, migration and invasion both in-vitro and in-vivo. Mechanistically, hypoxiadownregulates Quaking (QKI), an RNA-binding protein essential for the biogenesis of circ_0001766 by binding to introns 1 and 3 ofPDIA4 pre-mRNA. Reduced QKI expression under hypoxic conditions leads to decreased circ_0001766 levels in CRC. Circ_0001766acts as a competitive endogenous RNA, sponging miR-1203 to prevent the degradation of PPP1R3C mRNA. Loss of circ_0001766results in decreased PPP1R3C expression, leading to the activation of mTOR signaling and increased phosphorylation of Myc, whichpromotes CRC progression and rapamycin resistance. Our study reveals that overexpression of circ_0001766 or PPP1R3C in CRC cellsinhibits the mTOR and Myc pathway, thereby resensitizing cells to rapamycin. The combination of circ_0001766 or PPP1R3C withrapamycin markedly inhibits CRC cell proliferation and induces apoptosis by reducing rapamycin-induced Myc phosphorylation. Insummary, our study elucidates a critical circ_0001766/miR-1203/PPP1R3C axis that modulates CRC progression and rapamycinresistance. Our findings highlight circ_0001766 as a promising therapeutic target in CRC, providing a new avenue for enhancing theefficacy of existing treatments and overcoming drug resistance.Cell Death Discovery (2025) 11:192 ;

*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products